Team |
Vic Myer, PhD
Vic Myer, PhD

Vic Myer, PhD

President and Chief Scientific Officer at Chroma Medicine and Advisor at Atlas Venture

Vic Myer, Ph.D. is President and Chief Scientific Officer at Chroma Medicine and an Advisor at Atlas Venture. He also serves as an Independent Board member at KromaTid, Inc, an advisor to the NIH SCGE, and an SAB member at both Obsidian Therapeutics and Life Edit Therapeutics. Previously, he was Chief Technology Officer of Editas Medicine where he led the genome editing platform, CMC and chemistry departments. He has more than 20 years of experience in the biotech industry. At the Novartis Institutes for Biomedical Research, he led a large, technology focused target discovery, target validation and lead finding group in the Developmental and Molecular Pathways department for 11 years. Prior to Novartis, Vic focused on industrializing and using ‘omics technologies at Millennium, Akceli and Corning. He has B.S. from Cornell, a Ph.D. from Yale and did his post-doc at MIT/The Whitehead.

Connect with

Visionary science, driven by visionary values.

Our Mission

To rewrite the future by curing disease, making any edit, anywhere.

Our Vision

To pave the way to faster, safer, gene editing therapeutics that cure disease and improve patient lives.

Our Values

We’re guided by curiosity, rigor, and integrity. We believe in discovery and unlimited potential. We care about science and the lives of patients.